04/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

04/2024

Apr 8, 2024, 14:59 | Blog
Priya Ranganathan: Announcing a series of webinars on research methods, biostatistics, and publishing, as part of the CReDO Workshop
Amalya Sargsyan, Medical Oncologist at the Yeolyan Oncology and Hematology Center, shared a post by…
Apr 8, 2024, 14:54 | Insight
Piotr Wysocki: New data solidify the idea of omitting axillary dissection in breast cancer patients with clinically N0 disease and macrometastases in 1-2 sentinel LN
Piotr Wysocki, Head of the Clinical Oncology Department at Jagiellonian University Hospital, shared on LinkedIn:…
Apr 8, 2024, 14:44 | Blog
Lynn Schuchter: The class of 2024 Fellow Inductees into AACR are incredible
Lynn Schuchter recently responded to a post by Wafik S. El-Deiry, Director at the Legorreta…
Apr 8, 2024, 14:44 | Blog
Maite Gorostegui: Programa TELEO gives us a unique space to share knowledge and experience
Maite Gorostegui, Chair of the SIOP Global Mapping Programme, shared a post by Ana Carolina…
Apr 8, 2024, 14:41 | Societies
Chi Van Dang receives the AACR Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research
AACR  recently shared on X: "We congratulate the recipient of the AACR Margaret Foti Award for…
Apr 8, 2024, 14:35 | Insight
Biagio Ricciuti: Our collaborative effort to characterize MET kinase domain mutations as novel and targetable alterations in NSCLC and other cancer types
Biagio Ricciuti, Medical Oncologist at Dana-Farber Cancer Institute, posted on X: "Our collaborative effort to…
Apr 8, 2024, 14:32 | Blog
European Cancer Organisation - How can we improve cancer screening, prevention and access to treatment in Italy?
European Cancer Organisation shared on their LinkedIn page: "How can we improve cancer screening, prevention,…
Apr 8, 2024, 14:32 | Blog
Martina Murphy: Grateful to the UF Medicine class of 2024 for this incredible honor
Martina Murphy, Associate Professor of medicine in the Division of Hematology and Oncology at the…
Apr 8, 2024, 14:26 | Insight
Shubh Goel: ADRIATIC Phase III trial for LS-SCLC couldn’t come at a more critical time for patients
Shubh Goel, VP and US Franchise Head, Immuno-Oncology and GI Tumors at AstraZeneca, shared a post…
Apr 8, 2024, 14:26 | Drugs
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Dana-Farber’s Breast Oncology Center posted on X: "We are leading a randomized Phase 2 trial for…
All: 1932 Posts: 1621 - 1630
Special Coverage